Hertraz Injection

✅ Targets HER2-positive tumors
✅ Inhibits cancer cell growth
✅ Reduces tumor recurrence
✅ Enhances survival rates
✅ Improves treatment outcomes

Hertraz Injection contains Trastuzumab.

SKU: N/A Kategori: Medicin mod kræft, Kategorioversigt, Kroniske tilstande Tag: Hertraz Injection, Trastuzumab

✓ Medicinsk gennemgået af Morgan Ellis — Apoteksforsker · 8 års erfaring · Sidst gennemgået: maj 2026

Krypteret betaling

Krypto betaling giver 10% rabat

Diskret levering over hele verden

1.400+ kunder · 50+ lande

Hurtigt svar

Hertraz Injection is specialist-supervised oncology agent — administered under hospital supervision. Read the dosing, side-effect, and interaction sections below before use; the FAQs at the bottom cover the most common questions.

Hvad du får med MedsBase: WHO-GMP certificeret producent · Diskret emballage · Verdensomspændende forsendelse · 1.400+ verificerede kundeanmeldelser

📦 Hver ordre er dækket af vores Reshipment Assurance Policy — hvis din pakke ikke ankommer inden for 20 hverdage, sender vi en erstatning.

Hvorfor bestille fra MedsBase

Vores generiske medicin kommer fra WHO-GMP certificerede producenter og sendes verdensomspændende i diskret, neutral emballage — ingen medicinnavn på pakkens ydre. Kortbetalinger håndteres af en reguleret processor (kontoudtogsbeskrivelser inkluderer en reguleret betalingsprocessor — aldrig “MedsBase” eller medicinnavn). Crypto og SEPA bankoverførsel accepteres også. Hver ordre er dækket af vores Reshipment Assurance Policy.

Produktoverblik

Hertraz Injection is a medication containing the active ingredient Trastuzumab, available in vial form with a concentration of 440mg per vial. Trastuzumab is a monoclonal antibody used in the treatment of certain types of cancer, including breast cancer and gastric cancer. It is a targeted therapy that works by binding to specific receptors on cancer cells, inhibiting their growth and promoting cell death. Hertraz Injection is administered intravenously under the supervision of a healthcare professional.

Anvendelser

Hertraz Injection is indicated for the treatment of HER2-positive breast cancer, either alone or in combination with other chemotherapy agents. It is also used in combination with other drugs to treat HER2-positive metastatic gastric or gastroesophageal junction adenocarcinoma. HER2-positive cancers overexpress the human epidermal growth factor receptor 2 (HER2), and Trastuzumab specifically targets these receptors to inhibit cancer cell proliferation.

Brugsanvisning

Hertraz Injection is administered as an intravenous infusion by a healthcare provider in a clinical setting. The dosage and infusion rate are determined based on the patient’s body weight and medical condition. Prior to administration, the vial should be inspected visually for any particulate matter or discoloration. The injection should be given over a specified period, and patients are monitored for any signs of infusion-related reactions during and after the infusion.

Virkemåde

Trastuzumab, the active ingredient in Hertraz Injection, is a monoclonal antibody that targets and binds to the HER2 receptors present on the surface of cancer cells. By binding to these receptors, Trastuzumab inhibits downstream signaling pathways that promote cell proliferation and survival. Additionally, it can stimulate the immune system to attack HER2-positive cancer cells, further enhancing its anticancer effects. This targeted approach helps to selectively destroy cancer cells while minimizing damage to healthy tissues.

Dosering og administration

The recommended dosage of Hertraz Injection varies depending on the type and stage of cancer being treated, as well as other factors such as the patient’s weight and overall health. It is typically administered intravenously every 1 to 3 weeks, with the dosage adjusted based on the patient’s tolerance and response to treatment. Treatment duration may vary, and patients should follow the dosing schedule recommended by their healthcare provider.

Fordele

Effective in the treatment of HER2-positive breast cancer and gastric cancer
Targeted therapy with minimal impact on healthy cells
Can be used alone or in combination with other chemotherapy agents
May improve overall survival and reduce the risk of cancer recurrence
Well-tolerated with manageable side effects compared to traditional chemotherapy

Almindelige bivirkninger

Common side effects of Hertraz Injection may include infusion-related reactions, such as fever, chills, nausea, vomiting, headache, fatigue, and allergic reactions. Some patients may experience cardiotoxicity, manifested as decreased heart function or heart failure, and monitoring of cardiac function is recommended during treatment.

Advarsler

Patients receiving Hertraz Injection should be monitored closely for signs of cardiac toxicity, particularly those with pre-existing heart conditions or a history of cardiac dysfunction. The medication should be used with caution in pregnant or breastfeeding women, as it may harm the developing fetus or nursing infant. Prior to initiation of treatment, patients should undergo thorough cardiac evaluation, and concomitant use with anthracycline-based chemotherapy should be avoided due to increased risk of cardiotoxicity.

Opbevaringsinformation

Hertraz Injection should be stored in its original packaging at controlled room temperature, away from light and moisture. The vials should be protected from freezing and kept out of the reach of children and pets. Unused portions of the medication should be discarded properly according to local regulations.

Ansvarsfraskrivelse:

Vores eneste hensigt er at sikre, at forbrugerne får information, der er ekspertgransket, nøjagtig og pålidelig. Dog bør oplysningerne heri IKKE bruges som erstatning for rådgivning fra en kvalificeret læge. Oplysningerne her er kun til informationsformål. Dette dækker muligvis ikke alle mulige bivirkninger, lægemiddelinteraktioner, advarsler eller påmindelser. Konsulter venligst din læge og drøft alle dine spørgsmål relateret til enhver sygdom eller medicin. Vi har til hensigt at støtte, ikke erstatte, læge-patient-forholdet.

Ofte stillede spørgsmål

How does Hertraz Injection work?

Hertraz Injection is a specialist oncology agent — refer to the prescribing centre's treatment protocol for the specific indication, dose, and cycle. The mechanism, dose-by-indication tables, and contraindication list above give the molecule-specific clinical detail.

How quickly does Hertraz Injection work?

treatment cycles are individualised; response is monitored on imaging, blood markers, and clinical assessment per protocol. Read the indication-specific dosing section above for the schedule that applies to your case.

Hvad er de mest almindelige bivirkninger?

Bivirkningsprofilen afhænger af molekylet og dosen. Den kliniske sektion ovenfor lister de hyppige, lejlighedsvis og sjældne bivirkninger, der kan forventes, samt de advarselstegn, der kræver øjeblikkelig medicinsk vurdering.

Can I take Hertraz Injection with food or alcohol?

Interaktioner med mad og alkohol varierer afhængigt af molekylet. Tjek ovenstående tabel over lægemiddelinteraktioner for de specifikke regler, der gælder for mad, alkohol og samtidig medicin.

Hvad skal jeg gøre, hvis jeg glemmer en dosis?

Generelt skal du tage den glemte dosis, så snart du kommer i tanke om det, medmindre det er tæt på den næste planlagte dosis, hvor du så skal springe den over – tag aldrig en dobbeltdosis. Specifikke molekyler har specifikke regler; doseringsafsnittet ovenfor angiver, om dette lægemiddel har nogen ikke-standard håndtering af glemte doser.

Where can I order Hertraz Injection from MedsBase?

MedsBase ships Hertraz Injection discreetly worldwide from a WHO-GMP certified manufacturer. Card payments are processed through a regulated crypto on-ramp — your bank statement shows the processor name (a regulated card-payment processor), never “MedsBase” or any medication name. Every order is covered by our 20-business-day Reshipment Assurance.